NCT07372365
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China
Clinical trial condition
Immunoproliferative Disorders
Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.
9,958 public trials
2,018 recruiting studies
Immunoproliferative Disorders trial results
NCT06208657
- Conditions
- Central Nervous System Neoplasms, Childhood Brain Tumor, Childhood Cancer, +18 more
- Locations
-
- John Hunter Children's Hospital Newcastle, New South Wales, Australia
- Sydney Children's Hospital, Randwick Sydney, New South Wales, Australia
- The Children's Hospital at Westmead Sydney, New South Wales, Australia
- Queensland Children's Hospital Brisbane, Queensland, Australia
NCT05371132
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
NCT06371768
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +36 more
- Locations
-
- Duke Cancer Institute Durham, North Carolina, United States
NCT06492837
- Conditions
- Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
- Locations
-
- Royal Adelaide Hospital Adelaide, Australia
- Liverpool Hospital Liverpool, Australia
- St. Vincent Hospital Melbourne Melbourne, Australia
- Princess Alexandra Hospital Woolloongabba, Australia
Recruiting
Clinical Study of O&D-001 Injection in the Treatment of Relapsed or Refractory Multiple Myeloma
NCT07369895
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
- Locations
-
- Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
NCT05921253
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +11 more
- Locations
-
- Stephenson Cancer Center Oklahoma City, Oklahoma, United States
- Stephenson Cancer Center- Tulsa Tulsa, Oklahoma, United States
NCT06667687
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +12 more
- Locations
-
- Carolina BioOncology Institute /ID# 265259 Huntersville, North Carolina, United States
- Willamette Valley Cancer Institute and Research Center /ID# 270945 Eugene, Oregon, United States
- Texas Oncology - Central/South Texas /ID# 270946 Austin, Texas, United States
- START Mountain Region /ID# 267592 West Valley City, Utah, United States
- Conditions
- Acute Lymphoblastic Leukemia, High Risk, Acute Lymphoblastic Leukemia, Relapse, Acute Myeloid Leukemia, High Risk, +18 more
- Locations
-
- National medical research center of pediatric haematology, oncology and immulogy named after Dmytriy Rogachyov, Moscow, 117198 Moscow, Russia
Recruiting
CAR T-cell Therapy Directed to CD70 for Pediatric Patients With Hematological Malignancies
NCT06326463
- Conditions
- ALL, Childhood, AML, Childhood, Hematologic Diseases, +17 more
- Locations
-
- St. Jude Children's Research Hospital Memphis, Tennessee, United States